Emcure Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE168P01015
NSEID: EMCURE
BSEID: 544210
View on NSE | View on BSE

INR

1,640.15

30.1 (1.87%)

BSENSE

Apr 24

BSE+NSE Vol: 4.8 lacs

{
  "main_header": {
    "sid": 10039308,
    "name": "Emcure Pharma",
    "stock_name": "Emcure Pharma",
    "full_name": "Emcure Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/emcure-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,640.15",
    "chg": 30.1,
    "chgp": "1.87%",
    "dir": 1,
    "prev_price": "1,610.05",
    "mcapval": "31,443.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544210,
    "symbol": "EMCURE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE168P01015",
    "curr_date": "Apr 24",
    "curr_time": "",
    "bse_nse_vol": "4.8 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 24, 2026",
    "traded_date_str": "2026 04 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/emcure-pharma-10039308-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Emcure Pharmaceuticals Ltd Declines 1.80%: Mixed Technicals and Valuation Weigh on Stock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-declines-180-mixed-technicals-and-valuation-weigh-on-stock-3961999",
        "imagepath": "",
        "date": "2026-04-25 10:00:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Apr 20:</strong> Stock opens at Rs.1,670.25, declines 2.40% amid technical momentum shift</p>\n                    <p><strong>Apr 21:</strong> MarketsMOJO downgrades rating to Hold citing mixed signals</p>\n                    <p><strong>Apr 22:</strong> Slight recovery with 0.21% gain despite broader market weakness</p>\n                    <p><strong>Apr 23-24:</strong> Price rebounds with gains of 0.91% and 1.87% respectively, but weekly close remains below open</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,670.25</div></div>\n                    <div..."
      },
      {
        "title": "Emcure Pharmaceuticals Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-3957292",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EmcurePharmaceu_mojoScore_3957292.png",
        "date": "2026-04-22 08:30:06",
        "description": "Emcure Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 21 April 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and market-beating returns, evolving technical signals and valuation concerns have tempered enthusiasm, prompting a more cautious stance from analysts."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3955204",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EmcurePharmaceu_technicaldot_3955204.png",
        "date": "2026-04-21 08:06:56",
        "description": "Emcure Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend, reflecting a complex interplay of indicator signals. Despite a modest day decline of 2.40%, the stock’s longer-term performance remains robust, supported by strong moving averages and bullish monthly Bollinger Bands, while some indicators suggest caution ahead."
      },
      {
        "title": "Emcure Pharmaceuticals Gains 4.34%: 6 Key Factors Driving the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-gains-434-6-key-factors-driving-the-rally-3951838",
        "imagepath": "",
        "date": "2026-04-18 10:02:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> Stock opens strong at Rs.1,630.15 (+1.84%) despite Sensex decline</p>\n                    <p><strong>16 Apr:</strong> Emcure hits new 52-week and all-time high at Rs.1,673.6; rating upgraded to Buy</p>\n                    <p><strong>17 Apr:</strong> Stock reaches fresh 52-week high of Rs.1,688 and closes at Rs.1,670.25 (+1.94%)</p>\n                    <p><strong>17 Apr:</strong> Technical momentum shifts bullish with strong financials underpinning rally</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,600.75</div></div>\n                ..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1688",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-new-52-week-high-at-rs1688-3951116",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EmcurePharmaceu_priceRelatedfactors_3951116.png",
        "date": "2026-04-17 15:35:46",
        "description": "Surging past its previous peaks, Emcure Pharmaceuticals Ltd touched a fresh 52-week high of Rs 1688 on 17 Jun 2026, marking a remarkable 53.54% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained fundamental performance, setting the stage for a compelling price rally."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Emcure Pharmaceuticals Ltd Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-all-time-high-amid-robust-financial-performance-3951109",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EmcurePharmaceu_priceRelatedfactors_3951109.png",
        "date": "2026-04-17 15:22:35",
        "description": ""
      },
      {
        "title": "Emcure Pharmaceuticals Upgraded to Buy on Strong Financials and Technical Momentum",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/emcure-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-technical-momentum-3950286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EmcurePharmaceu_mojoScore_3950286.png",
        "date": "2026-04-17 08:24:03",
        "description": "Emcure Pharmaceuticals Ltd has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement across technical indicators, financial trends, valuation metrics, and overall quality. The company’s robust quarterly results, strong management efficiency, and positive market momentum have collectively driven this reassessment, signalling renewed investor confidence in its growth prospects within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Emcure Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-3950187",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EmcurePharmaceu_technicaldot_3950187.png",
        "date": "2026-04-17 08:04:47",
        "description": "Emcure Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend, supported by a confluence of positive signals across key indicators such as MACD, Bollinger Bands, and moving averages. Despite a slight dip in the daily price, the stock’s medium- and long-term technicals suggest strengthening investor confidence and a favourable outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1673.6",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/emcure-pharmaceuticals-ltd-hits-new-52-week-high-at-rs16736-3948834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EmcurePharmaceu_priceRelatedfactors_3948834.png",
        "date": "2026-04-16 09:48:13",
        "description": "Surging to a new 52-week high of Rs 1,673.6 on 16 Jun 2026, Emcure Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming the Sensex’s modest 1.79% gain over the past year with a 60.85% rally. This milestone caps a sustained uptrend supported by a confluence of bullish technical indicators across multiple timeframes."
      }
    ],
    "total": 391,
    "sid": "10039308",
    "stock_news_url": "https://www.marketsmojo.com/news/emcure-pharmaceuticals-10039308"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2026",
      "details": "Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "02-Apr-2026",
      "details": "Press Release Titled Emcure Pharma Reduces Poviztra Starting Dose Price by 55% to Expand Patient Access.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "01-Apr-2026",
      "details": "Acquisition by step-down subsidiary and amalgamation",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Emcure Pharmaceuticals Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Emcure Pharmaceuticals Ltd Declines 1.80%: Mixed Technicals and Valuation Weigh on Stock

2026-04-25 10:00:52

Key Events This Week

Apr 20: Stock opens at Rs.1,670.25, declines 2.40% amid technical momentum shift

Apr 21: MarketsMOJO downgrades rating to Hold citing mixed signals

Apr 22: Slight recovery with 0.21% gain despite broader market weakness

Apr 23-24: Price rebounds with gains of 0.91% and 1.87% respectively, but weekly close remains below open

Week Open

Rs.1,670.25

Read full news article

Emcure Pharmaceuticals Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-04-22 08:30:06

Emcure Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 21 April 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and market-beating returns, evolving technical signals and valuation concerns have tempered enthusiasm, prompting a more cautious stance from analysts.

Read full news article

Emcure Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-21 08:06:56

Emcure Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend, reflecting a complex interplay of indicator signals. Despite a modest day decline of 2.40%, the stock’s longer-term performance remains robust, supported by strong moving averages and bullish monthly Bollinger Bands, while some indicators suggest caution ahead.

Read full news article

Emcure Pharmaceuticals Gains 4.34%: 6 Key Factors Driving the Rally

2026-04-18 10:02:09

Key Events This Week

13 Apr: Stock opens strong at Rs.1,630.15 (+1.84%) despite Sensex decline

16 Apr: Emcure hits new 52-week and all-time high at Rs.1,673.6; rating upgraded to Buy

17 Apr: Stock reaches fresh 52-week high of Rs.1,688 and closes at Rs.1,670.25 (+1.94%)

17 Apr: Technical momentum shifts bullish with strong financials underpinning rally

Week Open

Rs.1,600.75

...

Read full news article

Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1688

2026-04-17 15:35:46

Surging past its previous peaks, Emcure Pharmaceuticals Ltd touched a fresh 52-week high of Rs 1688 on 17 Jun 2026, marking a remarkable 53.54% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained fundamental performance, setting the stage for a compelling price rally.

Read full news article

Strong Momentum Meets Stretched Valuations as Emcure Pharmaceuticals Ltd Reaches All-Time High

2026-04-17 15:22:35

Read full news article

Emcure Pharmaceuticals Upgraded to Buy on Strong Financials and Technical Momentum

2026-04-17 08:24:03

Emcure Pharmaceuticals Ltd has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement across technical indicators, financial trends, valuation metrics, and overall quality. The company’s robust quarterly results, strong management efficiency, and positive market momentum have collectively driven this reassessment, signalling renewed investor confidence in its growth prospects within the Pharmaceuticals & Biotechnology sector.

Read full news article

Emcure Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-04-17 08:04:47

Emcure Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend, supported by a confluence of positive signals across key indicators such as MACD, Bollinger Bands, and moving averages. Despite a slight dip in the daily price, the stock’s medium- and long-term technicals suggest strengthening investor confidence and a favourable outlook within the Pharmaceuticals & Biotechnology sector.

Read full news article

Broad-Based Technical Strength Lifts Emcure Pharmaceuticals Ltd to 52-Week High of Rs 1673.6

2026-04-16 09:48:13

Surging to a new 52-week high of Rs 1,673.6 on 16 Jun 2026, Emcure Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming the Sensex’s modest 1.79% gain over the past year with a 60.85% rally. This milestone caps a sustained uptrend supported by a confluence of bullish technical indicators across multiple timeframes.